-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
DaVita Inc. (NYSE:DVA) Shares Sold by Bank of New York Mellon Corp
DaVita Inc. (NYSE:DVA) Shares Sold by Bank of New York Mellon Corp
Bank of New York Mellon Corp lessened its holdings in shares of DaVita Inc. (NYSE:DVA – Get Rating) by 5.7% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 573,063 shares of the company's stock after selling 34,852 shares during the quarter. Bank of New York Mellon Corp owned 0.64% of DaVita worth $47,432,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Ellevest Inc. increased its position in DaVita by 1,388.0% during the 3rd quarter. Ellevest Inc. now owns 372 shares of the company's stock worth $31,000 after purchasing an additional 347 shares in the last quarter. Eisler Capital UK Ltd. acquired a new stake in DaVita during the 3rd quarter worth approximately $35,000. Parkside Financial Bank & Trust grew its position in DaVita by 88.6% in the first quarter. Parkside Financial Bank & Trust now owns 313 shares of the company's stock valued at $35,000 after acquiring an additional 147 shares in the last quarter. Neo Ivy Capital Management acquired a new stake in DaVita in the third quarter valued at approximately $40,000. Finally, Wipfli Financial Advisors LLC acquired a new stake in DaVita in the third quarter valued at approximately $44,000. Institutional investors and hedge funds own 86.52% of the company's stock.
Get DaVita alerts:DaVita Stock Performance
DaVita stock opened at $76.12 on Friday. The stock has a 50 day moving average of $80.61 and a 200-day moving average of $80.17. DaVita Inc. has a 52 week low of $65.28 and a 52 week high of $124.81. The stock has a market cap of $6.88 billion, a P/E ratio of 13.17, a price-to-earnings-growth ratio of 1.57 and a beta of 0.95. The company has a current ratio of 1.20, a quick ratio of 1.16 and a debt-to-equity ratio of 9.92.
DaVita (NYSE:DVA – Get Rating) last announced its quarterly earnings data on Wednesday, February 22nd. The company reported $1.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.88 by $0.23. DaVita had a return on equity of 74.02% and a net margin of 4.83%. The firm had revenue of $2.92 billion for the quarter, compared to analysts' expectations of $2.93 billion. During the same period last year, the business posted $2.02 earnings per share. The firm's revenue for the quarter was down .9% on a year-over-year basis. On average, analysts expect that DaVita Inc. will post 5.93 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Several analysts have issued reports on DVA shares. StockNews.com started coverage on shares of DaVita in a research report on Thursday, March 16th. They issued a "buy" rating for the company. Truist Financial increased their price objective on shares of DaVita from $84.00 to $90.00 and gave the company a "hold" rating in a research report on Thursday, February 23rd. Sanford C. Bernstein started coverage on shares of DaVita in a research report on Tuesday, March 7th. They issued a "market perform" rating for the company. Cowen increased their price objective on shares of DaVita from $76.00 to $90.00 and gave the company an "outperform" rating in a research report on Thursday, February 23rd. Finally, Deutsche Bank Aktiengesellschaft increased their target price on DaVita from $72.00 to $85.00 in a research note on Thursday, February 23rd. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $86.43.
Insider Buying and Selling
In related news, Director Charles Berg sold 1,431 shares of the firm's stock in a transaction on Thursday, March 9th. The stock was sold at an average price of $75.13, for a total transaction of $107,511.03. Following the transaction, the director now directly owns 15,733 shares in the company, valued at $1,182,020.29. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 1.00% of the stock is currently owned by company insiders.
DaVita Company Profile
(Get Rating)
DaVita, Inc engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure.
Featured Articles
- Get a free copy of the StockNews.com research report on DaVita (DVA)
- Dividend King Genuine Parts Company Upgraded On Profit Guidance
- The Bottom Is In For Accenture
- 11 Best Consumer Discretionary Stocks of 2023
- 5 Best Dividend Capture Stocks
- 10 Best Consumer Discretionary ETFs
Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.
纽约梅隆银行(Bank of New York Mellon Corp.)在最近提交给美国证券交易委员会的文件中称,该公司第三季度减持了5.7%的DaVita Inc.股票。该机构投资者在本季度出售了34,852股后,持有该公司573,063股股票。截至最近提交给美国证券交易委员会的文件,纽约梅隆银行持有DaVita 0.64%的股份,价值47,432,000美元。
其他机构投资者和对冲基金最近也买卖了该公司的股票。Ellevest Inc.在第三季度将其在DaVita的头寸增加了1388.0%。Ellevest Inc.现在持有372股该公司股票,价值3.1万美元,上个季度又购买了347股。艾斯勒资本英国有限公司在第三季度收购了DaVita价值约3.5万美元的新股份。第一季度,Parkside Financial Bank&Trust在DaVita的头寸增加了88.6%。Parkside Financial Bank&Trust现在拥有该公司313股股票,价值3.5万美元,上个季度又购买了147股。Neo Ivy Capital Management在第三季度收购了DaVita的新股份,价值约为40,000美元。最后,Wipfli Financial Advisors LLC在第三季度收购了DaVita的新股份,价值约为4.4万美元。机构投资者和对冲基金持有该公司86.52%的股票。
到达达维塔警报:达维塔股票表现
DaVita的股票周五开盘报76.12美元。该股的50日移动均线切入位在80.61美元,200日移动均线切入位在80.17美元。DaVita Inc.的股价为52周低点65.28美元,52周高点为124.81美元。该股市值为68.8亿美元,市盈率为13.17倍,市盈率为1.57倍,贝塔系数为0.95。该公司的流动比率为1.20,速动比率为1.16,债务权益比率为9.92。
DaVita(纽约证券交易所代码:DVA-GET Rating)最近一次公布季度收益数据是在2月22日星期三。该公司公布本季度每股收益(EPS)为1.11美元,比普遍预期的0.88美元高出0.23美元。DaVita的股本回报率为74.02%,净利润率为4.83%。该公司当季营收为29.2亿美元,高于分析师预期的29.3亿美元。去年同期,该业务公布的每股收益为2.02美元。该公司本季度的收入同比下降了0.9%。分析师平均预计,DaVita Inc.本财年每股收益将达到5.93欧元。
分析师升级和下调评级
几位分析师已经发布了关于DVA股票的报告。StockNews.com在3月16日星期四的一份研究报告中开始对DaVita的股票进行报道。他们对该公司的评级为“买入”。Truist Financial在2月23日星期四的一份研究报告中将DaVita的股票目标价从84.00美元上调至90.00美元,并给予该公司“持有”评级。桑福德·C·伯恩斯坦在3月7日星期二的一份研究报告中开始报道DaVita的股票。他们对该公司进行了“市场表现”评级。考恩在2月23日(星期四)的一份研究报告中将DaVita的股票目标价从76.00美元上调至90.00美元,并给予该公司“跑赢大盘”的评级。最后,德意志银行Aktiengesellschaft在2月23日星期四的一份研究报告中将DaVita的目标价从72.00美元上调至85.00美元。一名股票研究分析师将该股评级为卖出,5名分析师给予持有评级,两名分析师给予该股买入评级。根据MarketBeat.com的数据,该股目前的平均评级为持有,共识目标价为86.43美元。
内幕买卖
在相关新闻中,董事查尔斯·伯格在3月9日星期四的一次交易中出售了1,431股该公司的股票。该股以75.13美元的平均价格出售,总成交金额为107,511.03美元。交易完成后,董事现在直接拥有该公司15,733股股份,价值1182,020.29美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可通过美国证券交易委员会网站。1.00%的股份目前由公司内部人士持有。
DaVita公司简介
(获取评级)
DaVita,Inc.从事医疗保健服务的提供。它通过以下两个部门运作:美国透析和相关实验室服务,以及其他辅助服务和战略倡议。美国透析及相关实验室服务部门在美国为慢性肾功能衰竭患者提供肾脏透析服务。
专题文章
- 免费获取StockNews.com关于DaVita(DVA)的研究报告
- 红利王正品配件公司利润指引升级
- 埃森哲的底部已经到了
- 2023年11只最佳非必需消费品股票
- 5只最佳股利捕捉股
- 十大最佳消费者可自由支配ETF
接受《达维塔日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对DaVita和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧